Coeptis Therapeutics

$Coeptis Therapeutics(COEP)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001683168-26-000618  Act: 33  Size: 18 KB 网页链接

$Coeptis Therapeutics(COEP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-26-001026  Size: 6 KB 网页链接

$Coeptis Therapeutics(COEP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-26-001029  Size: 6 KB 网页链接

$Coeptis Therapeutics(COEP)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001683168-26-002026  Act: 34  Size: 8 MB 网页链接

$Coeptis Therapeutics(COEP)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000102909-26-000409  Act: 34  Size: 7 KB 网页链接

$Coeptis Therapeutics(COEP)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000102909-26-000137  Act: 34  Size: 8 KB 网页链接

$Coeptis Therapeutics(COEP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-26-001024  Size: 6 KB 网页链接

$Coeptis Therapeutics(COEP)$ 8-K Current report, item 3.01 Accession Number: 0001683168-26-000370  Act: 34  Size: 242 KB 网页链接

$Coeptis Therapeutics(COEP)$ 本文件详细说明了The Vanguard Group和Vanguard Total Stock Market Index Fund对Coeptis Therapeutics Holdings Inc.普通股的实际所有权情况。截至2025年12月31日，The Vanguard Group报告实际持有339,486股，占该类别股份的6.35%，拥有共同投票权和处置权。Vanguar...

$Coeptis Therapeutics(COEP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-26-001031  Size: 6 KB 网页链接

$Coeptis Therapeutics(COEP)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001683168-26-000617  Act: 34  Size: 29 KB 网页链接

$Coeptis Therapeutics(COEP)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001683168-26-002122  Act: 33  Size: 1 MB 网页链接

$Coeptis Therapeutics(COEP)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001683168-26-002123  Act: 33  Size: 1 MB 网页链接

$Coeptis Therapeutics(COEP)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001683168-26-000105  Act: 33  Size: 6 MB 网页链接

$Coeptis Therapeutics(COEP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-26-001032  Size: 6 KB 网页链接

$Coeptis Therapeutics(COEP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-26-001030  Size: 6 KB 网页链接

$Coeptis Therapeutics(COEP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-26-001028  Size: 6 KB 网页链接

$Coeptis Therapeutics(COEP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683168-26-001025  Size: 6 KB 网页链接

$Coeptis Therapeutics(COEP)$ 8-K Current report, item 5.07 Accession Number: 0001683168-26-000751  Act: 34  Size: 262 KB 网页链接

$Coeptis Therapeutics(COEP)$ 8-K Current report, items 5.02 and 8.01 Accession Number: 0001683168-26-000963  Act: 34  Size: 245 KB 网页链接